Literature DB >> 26099352

Actinic keratosis and squamous cell carcinoma: clinical and pathological features.

A Filosa1, G Filosa.   

Abstract

Actinic keratoses (AKs) are the most common keratinocytederived precancerous lesion in humans; they can be observed predominantly in fair-skinned individuals on sun-exposed surfaces. The primary risk factor for AKs is cumulative UV exposure from sunlight and/or tanning salons. AKs may present on a patient as a few detectable lesions. In addition to these, there are subclinical (invisible) AKs that are estimated to occur up to 10 times more often than visible AKs, since unprotected skin receives UV radiation from the sun. Clinical and subclinical AK lesions occurring in photo-damaged skin are called field cancerization. A field of change can be up to 7 cm around the primary lesions, resulting in lesions that are genetically similar. AKs are defined at the histologic level by dysplasia and consist of keratinocytes manifesting atypical nuclei that are enlarged, irregular, and hyperchromatic. The histopathologic changes noted in keratinocytic proliferative lesions involve disturbance of normal surface maturation. The degree and extent of keratinocytic atypia vary in these lesions. The atypical keratinocytes show enlarged nuclei with hyperchromasia, dyskeratosis and mitoses in any layer of the epidermis. In lesions of epidermal dysplasias, surface keratinocytic maturation is present, and a granular cell layer is usually noted. In intraepidermal carcinomas, there is full-thickness involvement of the epidermis by the atypical keratinocytes. While molecular techniques have improved our ability to distinguish squamous cell carcinomas (SCCs) from AKs, they have also reinforced the concept that non-melanoma skin cancers arise through a complex series of aberrations at the molecular level. AKs represent a spectrum along the continuum to invasive cancer. They are the most visible manifestation of field cancerization which creates a population of atypical cells with the potential to progress to invasive malignancy capable of metastasis. As the perilesional epithelium also has abnormalities due to photo exposure, understanding the existence of a "cancerization field" should be explained to the patients, reinforcing the importance of preventive clinical follow-up. The aim of the present review was to emphasize the histopathological aspect of the morphological spectrum in AK, and SCCs, also elucidating the clinicopathology of field canceriziation.

Entities:  

Mesh:

Year:  2015        PMID: 26099352

Source DB:  PubMed          Journal:  G Ital Dermatol Venereol        ISSN: 0392-0488            Impact factor:   2.011


  8 in total

1.  Noninvasive Long-term Monitoring of Actinic Keratosis and Field Cancerization Following Treatment with Ingenol Mebutate Gel 0.015.

Authors:  Orit Markowitz; Katie Wang; Amanda Levine; Michelle Schwartz; Sumeet Minhas; Eleanor Feldman; Daniel M Siegel
Journal:  J Clin Aesthet Dermatol       Date:  2017-10-01

Review 2.  Clinical utility of ingenol mebutate in the management of actinic keratosis: perspectives from clinical practice.

Authors:  Nevena Skroza; Nicoletta Bernardini; Ilaria Proietti; Concetta Potenza
Journal:  Ther Clin Risk Manag       Date:  2018-10-04       Impact factor: 2.423

3.  Protective effects of sunscreen (50+) and octatrienoic acid 0.1% in actinic keratosis and UV damages.

Authors:  Daniela Pinto; Anna Trink; Giammaria Giuliani; Fabio Rinaldi
Journal:  J Investig Med       Date:  2021-09-16       Impact factor: 2.895

4.  Identification of key genes in cutaneous squamous cell carcinoma: a transcriptome sequencing and bioinformatics profiling study.

Authors:  Dan-Dan Zou; Dan Xu; Yuan-Yuan Deng; Wen-Juan Wu; Juan Zhang; Ling Huang; Li He
Journal:  Ann Transl Med       Date:  2021-10

5.  A Randomized Double-Blind Parallel-Group Study to Evaluate the Long-Term Effects of a Medical Device Containing 0.3% Octatrienoic Acid in the Treatment of Grade III Actinic Keratosis.

Authors:  Graziella Babino; Stefano Caccavale; Daniela Pinto; Anna Trink; Giammaria Giuliani; Fabio Rinaldi; Giuseppe Argenziano
Journal:  Dermatol Ther (Heidelb)       Date:  2021-09-02

6.  Significant Biomarkers Identification Associated with Cutaneous Squamous Cell Carcinoma Progression.

Authors:  Cheng-Gang Qiu; Bin Shen; Xiao-Qi Sun
Journal:  Int J Gen Med       Date:  2022-03-02

Review 7.  New insights from non-invasive imaging: from prospection of skin photodamages to training with mobile application.

Authors:  G Pellacani; G Argenziano
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-06       Impact factor: 9.228

8.  Photoaging and actinic keratosis in Danish outdoor and indoor workers.

Authors:  Kasper Grandahl; Jonas Olsen; Kersti Brosbøl Engelund Friis; Ole Steen Mortensen; Kristina Sophie Ibler
Journal:  Photodermatol Photoimmunol Photomed       Date:  2019-02-20       Impact factor: 3.135

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.